Laura C. Michaelis, MD: In My Experience Question 1

May 07, 2020 By The ASCO Post Staff

How has the COVID-19 pandemic changed your approach to the selection of tyrosine kinase inhibitors for the treatment of patients with chronic myeloid leukemia?

Recorded April 24, 2020.

Related Content